Avoro Capital Advisors LLC Karyopharm Therapeutics Inc. Transaction History

Avoro Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $84.9 Million - $103 Million	-6,000,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $14.1 Million - $19.7 Million	-1,000,000 Reduced 14.29%	6,000,000 $87.6 Million
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $15.8 Million - $30.5 Million	1,100,000 Added 18.64%	7,000,000 $134 Million
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $1.38 Million - $2.95 Million	-150,000 Reduced 2.48%	5,900,000 $113 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $34.2 Million - $71.7 Million	6,050,000 New	6,050,000 $58.2 Million
Q2 2018 Aug 14, 2018	SELL	$12.0 - $19.88 $6.73 Million - $11.1 Million	-560,658 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $5.56 Million - $9.67 Million	560,658 New	560,658 $7.52 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $58.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.